series-b
Stage
1
Investors
About
Manas AI develops an AI-native biopharmaceutical platform that accelerates drug discovery by integrating physics-based and biologically informed AI models to improve speed, cost efficiency, and precision in developing therapeutics including small molecules, antibodies, and siRNA.
Explore Manas AI's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.